Tevosol

About:

Tevosol, a medical device company, has develop the Ex-Vivo Organ Support System to increase the number of available organs for transplant.

Website: http://www.tevosol.com

Twitter/X: tevosol

Top Investors: VA Angels

Description:

Tevosol, Inc. is a medical device company developing the Ex-Vivo Organ Support System (EVOSS™) with the goal of increasing the number of organs available for transplantation. EVOSS™ is a portable warm perfusion device intended to achieve better recovery of organs, better resuscitation of dysfunctional organs, and longer preservation of function with the opportunity for ex-vivo treatment and evaluation. The system consists of a common hardware platform with organ-specific single-use disposable cassettes for lungs, hearts, livers and kidneys.

Total Funding Amount:

6M CAD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Edmonton, Alberta, Canada

Founded Date:

2015-01-01

Contact Email:

kevin.ens(AT)tevosol.com

Founders:

Jayan Nagendran

Number of Employees:

1-10

Last Funding Date:

2019-08-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai